Tower Research Capital LLC (TRC) - ARCUS BIOSCIENCES INC ownership

ARCUS BIOSCIENCES INC's ticker is RCUS and the CUSIP is 03969F109. A total of 3 filers reported holding ARCUS BIOSCIENCES INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of ARCUS BIOSCIENCES INC
ValueSharesWeighting
Q3 2023$85,872
-42.7%
4,784
-35.2%
0.00%
-40.0%
Q2 2023$149,847
+210952.1%
7,378
+89.8%
0.01%
+150.0%
Q1 2023$71
-51.7%
3,888
-45.5%
0.00%
-66.7%
Q4 2022$147
-99.9%
7,134
+61.3%
0.01%
+200.0%
Q3 2022$115,000
-65.0%
4,424
-65.9%
0.00%
-71.4%
Q2 2022$329,000
+306.2%
12,974
+409.6%
0.01%
+600.0%
Q1 2022$81,000
-56.5%
2,546
-44.6%
0.00%
-66.7%
Q4 2021$186,000
-29.3%
4,596
-39.1%
0.00%
-57.1%
Q3 2021$263,000
+105.5%
7,551
+63.1%
0.01%
+133.3%
Q2 2021$128,000
-2.3%
4,629
-1.0%
0.00%
+50.0%
Q1 2021$131,000
+156.9%
4,675
+136.6%
0.00%0.0%
Q4 2020$51,000
-57.1%
1,976
-71.6%
0.00%
+100.0%
Q3 2020$119,000
-76.7%
6,968
-66.2%
0.00%
-95.2%
Q2 2020$510,000
+5000.0%
20,619
+1860.0%
0.02%
+2000.0%
Q3 2019$10,000
-83.6%
1,052
-78.4%
0.00%
-75.0%
Q1 2019$61,000
+6000.0%
4,870
+8596.4%
0.00%
Q3 2018$1,000
-96.3%
56
-97.5%
0.00%
-100.0%
Q2 2018$27,0002,2160.00%
Other shareholders
ARCUS BIOSCIENCES INC shareholders Q4 2023
NameSharesValueWeighting ↓
Invus Financial Advisors, LLC 1,612,077$50,877,00022.64%
Octagon Capital Advisors LP 2,489,974$78,584,00016.99%
Decheng Capital Management III (Cayman), LLC 869,790$27,451,0008.41%
BVF INC/IL 3,960,948$125,008,0005.00%
PFM Health Sciences, LP 3,431,010$108,283,0004.05%
EcoR1 Capital, LLC 3,265,101$103,047,0003.22%
Alphabet Inc. 2,563,441$80,902,0002.62%
Boxer Capital, LLC 1,432,200$45,200,0002.32%
SECTORAL ASSET MANAGEMENT INC 338,480$10,682,0001.90%
PARK CIRCLE Co 64,000$2,020,0001.68%
View complete list of ARCUS BIOSCIENCES INC shareholders